Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights

Apple Inc. (NASDAQ:AAPL) has reintroduced the blood-oxygen monitoring feature to its Apple Watch lineup after U.S. Customs and Border Protection approved imports of the devices — a decision that medical technology firm Masimo Corp. (NASDAQ:MASI) is now challenging in court. Masimo Accuses Customs…
|
||||
|
||||
You Might Like |